ABO-101, a Novel Gene Editing Therapy for Primary Hyperoxaluria Type 1, is Efficacious and Well Tolerated in NHPs and Results in High Fidelity Editing in Primary Hepatocytes

ABO-101 - Arbor Biotech

ABO-101 - Abeona Therap

https://www.sciencedirect.com/science/article/pii/S1525001625003028

Tia DiTommaso 1; Michael Kuefner 1; Anthony Garrity 1; Yurong Xin 1; Gabrielle Munoz 1; Ivan Kristanto 1; Lijun Liu 2; Florie Borel 1; Winston Yan 1; Daniel Ory 1; Pamela Stetkiewicz 1; John Murphy 1

Apr 10, 2025